Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amrep (AXR) Asset Writedowns and Impairment (2016 - 2019)

Amrep's Asset Writedowns and Impairment history spans 9 years, with the latest figure at -$38000.0 for Q1 2019.

  • On a quarterly basis, Asset Writedowns and Impairment fell 190.48% to -$38000.0 in Q1 2019 year-over-year; TTM through Jan 2019 was -$29000.0, a 163.04% decrease, with the full-year FY2017 number at $150000.0, up 123.88% from a year prior.
  • Asset Writedowns and Impairment hit -$38000.0 in Q1 2019 for Amrep, down from -$26000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for AXR hit a ceiling of $63000.0 in Q3 2018 and a floor of -$38000.0 in Q1 2019.
  • Historically, Asset Writedowns and Impairment has averaged $2125.0 across 4 years, with a median of -$7000.0 in 2017.
  • The widest YoY moves for Asset Writedowns and Impairment: up 400.0% in 2018, down 471.43% in 2018.
  • Tracing AXR's Asset Writedowns and Impairment over 4 years: stood at $18000.0 in 2016, then crashed by 61.11% to $7000.0 in 2017, then tumbled by 471.43% to -$26000.0 in 2018, then tumbled by 46.15% to -$38000.0 in 2019.
  • Business Quant data shows Asset Writedowns and Impairment for AXR at -$38000.0 in Q1 2019, -$26000.0 in Q4 2018, and $63000.0 in Q3 2018.